DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Chemiluminescence Analyzer (CLA) Market 2017-2021" report to their offering.
The global chemiluminescence analyzer market to grow at a CAGR of 6.41% during the period 2017-2021.
The report, Global Chemiluminescence Analyzer Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
One trend in the market is adoption of standardization and automation across the in vitro diagnostics industry. Due to the cost cutting in clinical lab fees, profitability, per test, is decreasing, which makes it necessary for the laboratories to focus on volume rather than value. There is also heavy pressure for quality, error-free results.
According to the report, one driver in the market is predictive and preventive medicine for early diagnosis and treatment. Globally, there is a trend in the world of medicine to transform from reactive healthcare to preventive healthcare. The changes as part of this trend will be propelled by new approaches to disease that will trigger the emergence of predictive and preventive medicine ultimately leading to personalized medicinal procedures.
- Abbott Laboratories
- Beckman Coulter
- bioMérieux SA
- F. Hoffmann-La Roche
Other prominent vendors
Ortho Clinical Diagnostics
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product type
PART 07: Market segmentation by end-user
PART 08: Geographical segmentation
PART 09: Decision framework
PART 10: Drivers and challenges
PART 11: Market trends
PART 12: Vendor landscape
PART 13: Key vendor analysis
PART 14: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/jmn8hp/global